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This study was conducted to evaluate the performance of Curcuma zanthorrhiza crude
extract after encapsulated in nanocrystalline starch, and to investigate the effect of the ratio of
nanocrystalline starches and maltodextrin; and the effect of concentration of temulawak extract
on nanocapsule characteristics, as well as encapsulation effect on the stability of antioxidant
activity. Preparation of nanocrystalline starch was conducted by using lintnerization and ethanol
precipitation of cassava and sago starches. Nanocrystalline starch and maltodextrin were used
as matrices with the ratio varied from 25:75, 50:50, and 75:25. The mixture of temulawak
extract and matrices were homogenized and spray dried. Nanocapsules characteristics included
the efficiency of encapsulation and drug loading, and antioxidant activity test were investigated.
Nanocrystalline cassava and sago starches were potentially modified starch that can be used
as the matrix for its low solubility and digestibility. It showed that the ratio of nanocrystalline
starch, maltodextrin, and concentration of temulawak extract significantly influenced the
nanocapsule characteristics. The best encapsulation condition obtained for nanocrystalline
matrix from cassava starch with the ratio of nanocrystalline starch: maltodextrin 25:75 (%w/w)
and 10% concentration of the temulawak extract, while for sago are 75:25 (%w/w) and 10%
concentration of temulawak extract. Nanocrystalline matrix from cassava starch revealed higher
encapsulation efficiency and antioxidant activity. The use of high temperatures during spray
drying affected by the slight decline of antioxidant activity of encapsulated temulawak extract.
Encapsulation of temulawak extract by using nanocrystalline starch and maltodextrin could
retain and protect its antioxidant activity.
Keywords: encapsulation; maltodextrin; nanocrystalline starch; spray drying; temulawak
extract

INTRODUCTION
Temulawak (Curcuma zanthorrhiza) is one of the
typical Indonesian plants that are widely used as herbal
medicine because it contains curcumin, an active
compound that is efficacious as the antioxidant, antiinflammatory, anti-cancer, anti-cholesterol, and for other
diseases. Research and clinical studies on the benefits
of curcumin have been widely reported by Dhillon et
al. (2008), Garcia et al. (2007), Sharma et al. (2001),
and Shoskes et al. (2005). Consumption of temulawak
is currently presented in the form of crude temulawak
extract or dried powder material. The absorption of
curcumin active compound in the human body in the
form of the crude extract is less effective because of the
nature of curcumin itself, which has low bioavailability
and insoluble in water. Besides that, curcumin has a high
sensitivity to pH, temperature, and light. Therefore, one
way to overcome these weaknesses is to increase the
solubility and bioavailability of curcumin and protect
curcumin by encapsulating the curcumin with a suitable
matrix.

Starch is widely used as an encapsulating agent because
it has several advantages, including biodegradable and
easy to be modified for improving its physicochemical
characteristics. Starches have also long been used as
additives to pharmaceutical preparations, either as fillers,
stabilizers, or drug coating agent. However, the use of
native starch as a matrix has some disadvantages such
as insoluble in cold water, produce unstable suspension
viscosity and high digestibility that does not match the
desired matrix characteristics. Therefore, it is necessary
to modify the starch by lintnerization, which eliminated
the amorphous fraction of starch at the branching point
of the amylopectin chains to become crystalline starch;
to decrease starch digestibility, and reduce the size of
starch to nano size (nanoparticles) through the process
of precipitation.
According to Barros & Stringheta (2006), the ideal
encapsulation matrix must have a film-forming property,
having an emulsifying property, biodegradable,
gastrointestinal resistant, has a low viscosity at high
concentrations, and indicating low hygroscopicity.
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However, it is not possible that all of these characteristics
can be met by using a single matrix. Therefore, the
mixing of two or more matrix components is more
common. In the process of binding of water-insoluble
curcumin-active compounds, the nanoparticle starch
matrix requires additional help of another matrix that
acts as a stabilizer and emulsifier, such as maltodextrin to
produce stable nanocapsules. Maltodextrin is a modified
starch that is produced from partial hydrolysis of starch.
Maltodextrins have fast dispersibility, low hygroscopic
properties, and strong film-forming ability and binding
strength (Srihari et al., 2010). Due to its strong binding
strength, maltodextrin was also used as a co-matrix in
this study. Previously Winarti et al. (2014) have reported
the application of sole nanoparticles from arrowroot
starch as an encapsulation matrix for curcumin. In this
study, the encapsulation was performed using sago and
cassava nanoparticle starches as carrier matrix, with the
addition of maltodextrin, which acts as a stabilizer and
emulsifier.
METHODS
Materials
Cassava and sago starches used in this research were
obtained from the local small-scale industry in Bogor,
Indonesia. The crude extract of temulawak was kindly
supplied from Indonesian Center for Agricultural
Postharvest Research and Development and produced
by using ethanol-extraction of dried Curcuma rhizome.
Preparation and Characterization of Nanocrystalline
Starch
The nanocrystalline cassava and sago starches were
prepared by two successive processes, i.e., lintnerization
and ethanol precipitation, according to Winarti et al.
(2014) methods. About 50% of the starch slurry was
dispersed in 2.2 N of HCl at 35oC and then incubated
on shaking incubator at 120 rpm for 6 h. The slurry was
neutralized by 1 N of NaOH, then washed with distilled
water and ethanol, and oven-dried at 40oC for overnight.
The lintnerized starch was then completely gelatinized.
Ethanol was added to the solution drop by drop with
slow stirring. The precipitate then oven-dried at 40oC
for overnight. Characterizations of nanocrystalline
cassava and sago starches were determined for solubility

and swelling power (Perez et al., 1999), and in vitro
starch digestibility by using porcine pancreatin amylase
(Anderson, et al., 2002).
Process of Encapsulation of Curcumin Extract
The procedure for the encapsulation process of curcumin
extract was modified from Winarti et al. (2014). Each
nanocrystalline starch was mixed with maltodextrin with
different composition ratios (starch: maltodextrin 25:75,
50:50, and 75:25). About 15 g of both starchy materials
were diluted in 150 ml water to produce 10% of starch
solution. The mixture was then dispersed and stirred at
70oC with a magnetic stirrer for 15 minutes, and then
stood to rehydrate for overnight. 5% and 10% (v/v) of
crude temulawak extract, which had been diluted with
ethanol with total dissolved solids ~20oBrix, was mixed
with a starch solution, and then homogenized with
Ultra Turrax for 10 minutes at 11000 rpm. The next
process was atomization and dried with a spray dryer
with inlet temperature conditions around 80oC and
outlet temperature 170°C. The obtained nanocapsules
were weighed and calculated its yield. Nanocapsules
characteristics included the efficiency of encapsulation
and drug loading (Herdini et al. 2010), and antioxidant
activity was investigated by DPPH (1,1-diphenyl-2picrylhydrazyl-Sigma) assay. DPPH was a stable free
radical. When the antioxidant reacted with DPPH, the
antioxidant could donate a hydrogen atom, and then
DPPH would convert to the reduced or nonradical form
(Diphenylpicrylhydrazine). This could be monitored by
the loss of the violet color to be a residual pale yellow
color (Molyneux, 2004). The antioxidant activity was
calculated as a percentage of antioxidant inhibition
against free radical components.
RESULTS
Herb active ingredient like curcumin, generated from
the rhizomes of Curcuma zanthorrhiza plant (local name
Temulawak), was one of the materials used in traditional
medicine.
Characteristics of Nanocrystalline Starch
The nanocrystalline starch was produced by two main
processes, namely lintnerization and gelatinized starch
precipitation. Lintnerization or slow acid hydrolysis

Table 1. Functional properties of nanocrystalline starch
Characteristics

Cassava Starch

Sago Starch

72.78

56.67

Swelling power (%)

226.38

249.15

Pancreatin amylase
digestibility (%)

71.67

80.25

Solubility
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Table 2. Characteristics of nanocapsules

Characteristics

Yield (%)

Encapsulation Efficiency (%)

Drug loading (%)

Antioxidant Activity (%)

Temulawak
Extract (%
v/v)

Matrices Ratio (Nanocrystalline Starch: Maltodextrin)
Cassava Starch

Sago Starch

25:75

50:50

75:25

25:75

50:50

75:25

5

32.75

34.64

35.52

31.46

30.02

37.52

10

37.73

37.64

36.95

43.62

44.13

33.19

5

56.28 ± 4.45

69.95 ± 2.81

32.89 ± 13.54

58.54 ± 0.18

52.78 ± 2.82

43.52 ± 3.35

10

69.78 ± 1.13

47.15 ± 0.50

37.18 ± 5.63

25.03 ± 14.90

37.31 ± 1.02

45.71 ± 3.98

5

0.14 ± 0.00

0.16 ± 0.01

0.14 ± 0.00

0.14 ± 0.00

0.15 ± 0.01

0.15 ± 0.01

10

0.24 ± 0.02

0.20 ± 0.01

0.18 ± 0.01

0.22 ± 0.01

0.25 ± 0.03

0.28 ± 0.01

5

32.76 ± 1.45

34.09 ± 5.50

39.29 ± 2.60

20.19 ± 2.07

31.30 ± 1.82

31.09 ± 2.12

10

85.25 ± 0.11

85.07 ± 2.14

82.79 ± 0.66

52.60 ±1.31

59.38 ± 1.03

61.47 ± 0.77

data presented in mean +/- standard deviation, except for the yield
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removed the amorphous parts of starch, and left the
crystalline starch known as Lintnerized starch. Ethanolprecipitation of gelatinized-lintnerized starch would
reduce the size from micrometer into nano-sized particles,
as well as the changes in its characteristics. The values of
solubility, swelling power, and digestibility of cassava
and nanocrystalline sago starch were shown in Table
1. The solubility value (57%) of sago nanocrystalline
starch was lower than that of cassava starch (73%), but
nanocrystalline sago starch had higher swelling power
(249%) and in vitro digestibility (80%).
Characteristics of Nanocapsules
Curcumin was insoluble in the water and had a high
sensitivity to pH, temperature, and light. Incorporation
of curcumin into the nano-starch matrix would enhance
its solubility and bioavailability, as well as protects
from environmental deterioration. The characteristic of
nanocapsules of the temulawak extract was shown in
Table 2. The yield for nanocapsule of temulawak extract
with cassava nanocrystalline starch was 32.75-37.64%,
while nanocrystalline sago starch was 30.02-44.13%.
The encapsulation efficiency (EE) showed the number
of active ingredients bound in the matrix calculated
from the amount of active ingredient added before
the encapsulation process. The results showed EE
nanocapsule matrix of nanocrystalline tapioca starch of
32.89-69.95%, and in nanocrystalline sago matrix of
33.19-58.54%.
The capability of the starch matrix to encapsulate the
active compound could be determined by drug loading
(DL) value. The results showed that the drug loading
of the nanocapsule matrix from nanocrystalline tapioca
was 0.14-0.24%, while the nanocrystalline sago matrix
was 0.14-0.28%. Both matrices have a high capability to
encapsulate active compounds. The matrices can increase
the encapsulated of active compounds from 10% of
temulawak extract (DL 0.18-0.28%) compared to lower
(5%) concentration (DL 0.14-0.16%). The highest DL
produced at 10% temulawak extract concentration. It was
found that the matrix with 75% ratio of nanocrystalline
sago starch and 25% maltodextrin produced DL with
the highest mean value. In the formulation, the ratio of
sago nanocrystalline starch: maltodextrin 75: 25 and
concentration of temulawak extract 10%, revealed a DL
value of 0.28 ± 0.01%.
Measurement of antioxidant activity was generally
conducted to evaluate the presence of oxidation
inhibition activity by antioxidant compounds contained
in temulawak extracts. The results (Table 2) showed
that the antioxidant activity produced by nanocapsule
nanocrystalline tapioca matrices were 32.76-85.25%,
higher compared to sago matrices (20.19-61.47%). The
value of antioxidant activity was correlated to DL value.
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The results showed that 10% of temulawak extract gave
higher (more than twice) antioxidant activity compared
to 5%. The best antioxidant activity was produced by
nanocapsule with the addition of 10% temulawak extract.
The increased concentration of added temulawak extract
caused the increment of encapsulated curcumin active
compound so that more DPPH compounds could be
reduced.
DISCUSSION
The nanocrystalline starch is a modified native starch that
was having a particle size of 20-50 nm and has crystalline
properties. Starches could form nanostructures because
the starch granules themselves were composed of nanoscale crystalline blocks with a diameter of 20-500 nm,
depending on the botanical origin. A granular block was
composed of layers consisting of crystalline lamellae
(5-6 nm) and amorphous lamellae (2-5 nm) (Gallant et
al., 1997).
The nanocrystalline starch was produced by two main
processes, namely lintnerization and starch precipitation.
Lintnerized starch produces crystalline starch, a
modified starch which had been cleavaged its long-chain
amylose fraction and its branching point α-1.6 inter
clusters of amylopectin chains, to produce short-chain
amylose fraction with lower molecular weight and to
form the crystalline structure by hydrolysis using the
strong acid. The more structures that were cleavaged
into simple sugars, resulting in lower starch digestibility.
Winterization also aimed to reduce the viscosity of starch
and increase its crystallinity (Srichuwong et al., 2005).
The precipitation process was conducted by slowly
adding organic solvents with rapid stirring. The formation
of starch nanoparticles occurred when the starch was
subjected to high-temperature treatment during the
gelatinization process and the presence of mechanical
agitation resulting in the destruction of covalent
and hydrogen bonds in the double helix structure of
amylopectin and melting of the crystalline part, resulting
in smaller particles up to nano size (Winarti et al., 2014).
It was reported that starch nanoparticles produced by
ethanol precipitation processes were ranged between
100-250 nm.
Based on Winarti et al. (2014), the solubility value
of nanocrystalline starch was lower than crystalline
(lintnerized) starch. Increasing the solubility in
lintnerization due to hydrolysis process had damaged the
granules and broke down the long starch chains into short
chains, made it more easily dissolved. The solubility of
nanocrystalline starch decreased due to the loss of water
molecules and ethanol precipitation particles. Ethanol
would replace the water molecules inside the material so
that the solubility tends to be low.
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Factors such as amylose-amylopectin ratio, amylose
content, and starch crystallinity influenced to swelling
power and solubility properties. Swelling or waterabsorption capacity in starch was essential in biomedical
or pharmaceutical applications, both as implants and
drug delivery systems. This was because the level of
the swelling equilibrium affected the solvent diffusion
coefficient across the matrix, surface properties, and
surface mobility, including its mechanical properties
(Pepas et al., 1996).
Encapsulation of water-insoluble active compounds in
the starch matrix was having difficulties in producing
an excellent mixture. Table 2 showed that 50:50 ratio of
nanocrystalline cassava starch and maltodextrin could
produce high EE (69.95%) with 5%. In this condition,
maltodextrin also acted as an emulsifier. This result was
similar to that reported by Paramera et al. (2011), which
encapsulated curcumin by using modified starch OSA
(EE value 60.4%) and with the addition of emulsifier
(Tween 80) and 56.2% for treatment without emulsifier
(Paramera et al., 2011). Other studies reported by Winarti
et al. (2014) produced nanocapsule with EE of 48.6969.59% using nanoparticle arrowroot starch. Increasing
the emulsifier concentrations resulted in smaller average
particle size of nanocapsule (Mirjazani et al., 2010).
This caused by the binding of the active compound in
the matrix due to its higher active surface area. In this
research, maltodextrins are also functioned as co-matrix,
thereby increasing the suspension viscosity caused by
preventing the migration of the active compounds from
the dispersed phase limit (Rafati et al., 1997).
The resulting drug loading (Table 2) was relatively low
(0.14-0.28), compared to the Paramera et al. (2011) as
2.8-2.9%. The matrix with 75% ratio of nanocrystalline
sago starch and 25% maltodextrin produced DL with
the highest mean value. In the formulation, the ratio of
sago nanocrystalline starch: maltodextrin 75:25 and the
concentration of temulawak extract 10%, revealed DL
value of 0.28 ± 0.01%.
The highest DL produced at 10% temulawak extract
concentration compared to 5% concentration. These
results followed a similar trend with Lin et al. (2009)
research, which showed a higher amount of encapsulated
curcumin with increasing added concentration of
curcumin. The amount of active compound loaded into
the matrix would influence the antioxidant activity.
The extract not only bound inside the matrix but also
adsorbed on the matrix surface. Antioxidant activity
was needed to determine the quality of antioxidants
and product stability during processing and storage, as
well as its implications to the human body. Wang et al.
(2009) reported the levels of curcumin obtained after
encapsulation, which decreased activity occurred very
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little or tended to be stable despite the heat treatment
with high temperature (80-100oC) and long heating time
(10-50 minutes) (Wang et al., 2009). The encapsulation
process would increase the resistance of the active
compounds to heat (Paramera et al., 2011).
CONCLUSION
Nanocrystalline starch from both cassava and sago
starches mixed with maltodextrin could be used to
encapsulate the curcumin extract and could protect and
maintain parts of its activity. The ratio of 25% of cassava
nanocrystalline starch and 75% of sago nanocrystalline
starch mixed with 25% and 75% of maltodextrin,
respectively, could produce nanocapsules with highest
encapsulation efficiency, drug loading, and antioxidant
activity.
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